Financhill
Back

Medifast 10K Form

Sell
17

MED
Medifast

Last Price:
26.09
Seasonality Move:
18.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive MED News And Ratings

See the #1 stock for the next 7 days that we like better than MED

MED Financial Statistics

Sales & Book Value

Annual Sales: $1.07B
Cash Flow: $5.44M
Price / Cash Flow: 3.25
Annual Sales: $19.29
Price / Book: 1.3

Profitability

EPS (TTM): 6.15000
Net Income (TTM): $67.76M
Gross Margin: $775.85M
Return on Equity: 35.22%
Return on Assets: 21.54%

Medifast Earnings Forecast

Key Medifast Financial Ratios

  • The Gross Profit Margin over the past 28 years for MED is 72.37%.
  • The Selling, General & Administrative Expenses for MED have been equal to 60.58% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 0.49% of Operating Income.
  • The Net Earning history of MED is 9.27% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 15 years.

Medifast Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Personal Care Products
Sector: Consumer Staples
Current Symbol: MED
CUSIP: 58470H
Website: medifastinc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.84
Quick Ratio: 2.03

Price-to-Earnings

Trailing P/E Ratio: 2.76
Forward P/E Ratio: 13.3

MED Technical Analysis vs Fundamental Analysis

Sell
17
Medifast (MED) is a Sell

Is Medifast a Buy or a Sell?

  • Medifast stock is rated a Sell
    The current Medifast [MED] share price is $25.14. The Score for MED is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.